Exactech’s new knee arthroplasty device receives FDA clearance: 4 observations

Exactech received clearance from the FDA to market the Optetrak Logic Constrained Condylar Prosthesis.

Advertisement

Here are four observations:

 

1. The device is intended for use in revision knee arthroplasty cases. It is also indicated for when previous devices have failed.

 

2. The system aims to achieve optimal implant placement and bone coverage.

 

3. The Optetrak Logic CC system will have limited availability in 2015 and a full market launch in 2016.

 

4. Exactech is a medical device company focusing on solutions for hip, knee shoulder and spine surgery.

 

More articles on devices:
SIGNUS develops ASCOT for spinal fusion — 7 things to know
Tyber Medical launches lateral retractor system — 5 things to know
Simponi receives CE mark — 5 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.